Objective-Pseudoxanthoma elasticum is an inherited metabolic disorder resulting from ABCC6 gene mutations. It is characterized by progressive calcification and fragmentation of elastic fibers in the skin, retina, and the arterial wall. Despite calcium accumulation in the arteries of patients with pseudoxanthoma elasticum, functional consequences remain unknown. In the present study, we investigated arterial structure and function in Abcc6 −/− mice, a model of the human disease. Approach and Results-Arterial calcium accumulation was evaluated using alizarin red stain and atomic absorption spectrometry. Expression of genes involved in osteochondrogenic differentiation was measured by polymerase chain reaction. Elastic arterial properties were evaluated by carotid echotracking. Vascular reactivity was evaluated using wire and pressure myography and remodeling using histomorphometry. Arterial calcium accumulation was 1.5-to 2-fold higher in Abcc6 −/− than in wild-type mice. Calcium accumulated locally leading to punctuate pattern. Old Abcc6 −/− arteries expressed markers of both osteogenic (Runx2, osteopontin) and chondrogenic lineage (Sox9, type II collagen). Abcc6 −/− arteries displayed slight increase in arterial stiffness and vasoconstrictor tone in vitro tended to be higher in response to phenylephrine and thromboxane A2. Pressure-induced (myogenic) tone was significantly higher in Abcc6 −/− arteries than in wild type. Arterial blood pressure was not significantly changed in Abcc6 −/− , despite higher variability.
P seudoxanthoma elasticum (PXE) is an inherited multisystem metabolic disorder affecting the connective tissue characterized by a progressive calcification and fragmentation of elastic fibers (elastorrhexis) in the skin, the Bruch's membrane of the eye, and the media of the arterial wall. The clinical expression of PXE consists of dermal lesions of esthetic concern, as well as retinal breaks and hemorrhage leading to visual impairment. 1, 2 ABCC6 encodes an ATP-binding cassette transporter from the subfamily C primarily expressed in the liver and to a lesser extent in the kidney. 3 ABCC6 expression is lower or absent in the tissues affected by PXE, and >300 distinct loss-of-function mutations affecting the ABCC6 gene have been identified 2 in patients with PXE. At present, the intracellular substrate(s) released into the bloodstream by ABCC6 and the remote pathomechanisms leading to aberrant arterial calcifications (ACs) and elastin fragmentation in connective tissues of patients with PXE remain unknown.
The consequences of medial calcification in PXE arteries are largely unknown. Mostly based on case reports, it was proposed that PXE affects various arterial fields, and that PXE arteries including coronary arteries are prone to an accelerated arteriosclerosis. 1, [4] [5] [6] Studies on humans have hypothesized specific arterial remodeling, including increased intima media thickness (IMT) with unchanged or reduced stiffness associated with increased arterial wall compressibility (ie, changes in wall cross-sectional area during the cardiac cycle) of the large-and medium-sized arteries. 7, 8 These manifestations are thought to result from the combined effect of elastocalcinosis and accumulation of proteoglycans in the media of arteries. 9, 10 In contrast to other calcifying arterial diseases, the PXE peripheral arterial disease remains atypical in many aspects: (1) peripheral arterial disease is a frequent clinical finding although characterized by rare or at least unreported limb amputation and acute ischemia 11 and (2) a fairly wellpreserved compressibility of the arterial wall as indicated by a low ankle-brachial index, despite mediacalcosis. 11 Altogether, these observations suggest a complex and singular remodeling of the arterial wall, including possible changes in vascular reactivity or at least changes in local blood flow supply. To date, the impact of ABCC6 deficiency on arterial reactivity, especially in the small-sized vasculature, remains largely unknown. Unspecific microangiopathy has been reported in the finger microcirculation 12 but overt clinical microcirculatory abnormalities have not yet been reported to our knowledge in this context. Two mouse models recapitulate the main histopathologic features of human PXE in a large extent. They display spontaneous age-related disseminated calcification mostly in tissues rich in elastic fibers (lung excepted), including arteries. [13] [14] [15] To date, data concerning the quantitative accumulation of calcium in the vasculature of Abcc6 −/− mice and the functional impact, if any, on arterial function are lacking. Of particular interest is the microvascular myogenic tone (MT) that plays a major role in the control of local blood flow. 16 Therefore, we studied both qualitatively and quantitatively the impact of calcium deposits within the arterial tree of Abcc6 −/− mice and determined the functional significance of this calcification by testing resistance (mesenteric and tail) and conductive (carotid) arteries.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Calcium Accumulation in the Vasculature of Abcc6 −/− Mice
Whole-organ imaging coupled to alizarin red staining was used to display the regional accumulation of calcium deposits in the whole arterial tree (Figure 1 ). Such calcium depositions were predominantly detected in the aortic arch ( Figure 1A -1C) and large arteries (thoracic aorta, Figure 1D ) and to a smaller extent medium-sized arteries, innominate artery ( Figure 1H ) carotid ( Figure 1K ), renal, and femoral arteries (not shown) of old Abcc6 −/− mice. Calcifications were detected in aortic trunks of Abcc6 −/− animals as early as 9 months of age, whereas no calcifications were macroscopically detected in control mice. A semi-quantitative description of arterial regions presenting calcification nodules is presented in Table 1 . Calcified area displayed heterogeneous patterns ranging from organized, that is, after elastic fibers in the aortic arch and descendent thoracic aorta ( Figure 1C and 1G) to more robust plaques ( Figure 1D and 1H) or punctuated spots in small size distal arteries such as tibial artery ( Figure 1E and 1F).
A colorimetric technique was used to evaluate calcium accumulation in various tissues of aged Abcc6 −/− mice (20-24 months). We found a significant accumulation of calcium in Abcc6 −/− mouse tissues: the vibrissae (1.32±0.13 versus 0.15±0.01 mg/g; P<0.0001), kidney (0.46±0.04 versus 0.06±0.01 mg/g; P=0.0014), and testis (0.17±0.04 versus 0.04±0.00 mg/g; P=0.032). No calcium deposition was found in the liver (Abcc6 −/− mice 0.05±0.01 versus wild-type [WT] 0.06±0.01 mg/g; P=0.74). Given the small size of arteries in mice, a quantitative spectrometric approach was used to evaluate calcium accumulation in these tissues. Figure 2 shows that, with the exception of tail artery, all analyzed Abcc6 −/− vascular territories accumulated calcium to a greater extent than those from WT mice (mean calcium load in mg/g of tissue was 0.17±0.03 and 0.30±0.04 in WT and Abcc6 −/− arteries, respectively; P=0.0089).
Quantification of Arterial Osteochondrogenic Markers
To further characterize cellular and molecular process of PXE-associated AC, we investigated the expression of key genes involved in smooth muscle cell (SMC) osteochondrogenic transdifferentiation using a quantitative polymerase chain reaction (PCR) approach in mesenteric resistance artery (MRA; Figure 3 ). To evaluate the effect of aging and Abcc6 deficiency, experiments were performed on 5-and 24-month animals of both genotypes. We found no difference linked to Abcc6 genotype in the expression levels of the investigated genes in 5-month-old animals with the exception of matrix metalloproteinases (Mmp2 and 9), which were overexpressed in mutant mice. Beside, the expression level of several genes was found to vary according to both age and genotype. In 24-month-old Abcc6 −/− mice we found a significant increased mRNA expression of the Runt-related transcription factor-2 (Runx2). SRY-boxcontaining gene-9 (Sox9) significantly increased according to the Abcc6 −/− genotype (P=0.047); however, the difference in aged-paired groups did not reached significance. The vitamin D receptor (Vdr) increased in arteries of old Abcc6 −/− mice; however, this difference did not reach significance (P=0.15). The transcription factor msh homeobox 2 (Msx2) was below the detection threshold. The expression of bone morphogenetic protein (Bmp)-2 and 4 decreased with aging but was not influenced by genotype, whereas 
Cardiovascular Parameter Evaluation
To evaluate the impact of calcification on arterial homeostasis, we measured cardiovascular variables on awaked animals. To avoid cardiovascular depression resulting from anesthesia, blood pressure was measured in conscious mice by plethysmography.
The results are summarized in Table 2 . In younger animals (from 4 to 12 months), no change was noted in Abcc6 −/− mice, when compared with the WT, except for pulse pressure, which was significantly lower in mutant mice (55±1 versus 49±2 mm Hg for WT and Abcc6 −/− mice, respectively). In older animals (16-24 months), heart rate was significantly higher (601±14 versus 679±12 bpm for WT and Abcc6 −/− mice, respectively). Of note, aged Abcc6 −/− mice displayed a much variable systolic blood pressure than the WT ( Figure 
Hemodynamics and Arterial Stiffness Evaluation in Abcc6 −/− Mice
Hemodynamics and arterial stiffness were evaluated by the echotracking method on the right carotid. The data are summarized in Table 3 . The diameter, IMT, and media cross-sectional area of the carotid were not different between Abcc6 −/− and agematched control mice. With aging, WT mice exhibited a shift of distensibility and wall strain curves to the left. The distensibility-pressure curves were shifted to the left in Abcc6 −/− mice ( Figure 4A ) as early as 9 months of age, indicating stiffer carotid. Values of incremental elastic modulus (Einc) and arterial wall stress at the mean arterial pressure were not significantly different between Abcc6 −/− and WT mice. However, the mean distensibility analyzed within the range of arterial pressure (80-100 mm Hg) and mean wall strain analyzed within the range of Einc of 300 to 800 kPa were significantly lower in Abcc6 −/− mice, when compared with those in WT mice (P=0.001 and P=0.01, respectively; Figure 4B , left and right histograms; Table 3 ). Significant differences were observed between genotypes only in the mice at 9 months of age. No significant interaction was observed between age and genotype.
Micro-and Macrovascular Reactivity in Abcc6 −/− Mice
In vitro isometric contraction experiments conducted on both resistance (mesenteric and tail) and compliant arteries (carotids) revealed limited changes in the arterial reactivity of Abcc6 −/− mice, when compared with their WT controls. The results obtained with MRA of 3-, 12-, and 24-month-aged animals are presented in Figure 5B . The contraction in response to α-1-adrenergic and thromboxane A2 receptors stimulation using phenylephrine and U46619 as agonists was equivalent in Abcc6 −/− animals, when compared with that in WT mice. Overall, despite a tendency toward a gain of contraction, neither the sensitivity (pD2) nor the potency (Emax) of vasoconstrictor agonists was modified ( Table 4 ). Sensitivity and potency of vasodilator were strictly superimposable, and no difference in the relaxation of Abcc6 −/− and WT arteries was observed irrespective of whether it was dependent (acetylcholine) or independent (sodium nitroprusside) of the endothelial function and integrity. The results of the experiments conducted on mesenteric, carotid, and tail arteries in 3-, 12-, and 24-month-old animals are summarized in Tables 4 and 5 .
Pressure-Induced MT in Resistance Arteries
In passive conditions, stepwise increases in pressure induced equivalent increases in diameter in both tail artery and MRA isolated from Abcc6 −/− and WT mice. As expected, the arterial diameter was higher in old animals, when compared with that in young animals, irrespective of the genotype ( Figure 6A and 6B). Although arterial diameter tended to be larger in Abcc6 −/− than in WT mice, this difference did not reach significance. 
Discussion
PXE is characterized by aberrant mineralization and elastic fiber fragmentation in connective tissues, such as the arterial wall. In humans, PXE is associated with significant vascular changes although the nature of the peripheral arterial disease remains unclear. The present study evaluated the impact of Abcc6 deficiency in a mouse model that recapitulates the features of connective tissue mineralization encountered in human PXE on the macro-and microvascular structure and function.
Arterial Calcification Pattern in Abcc6 −/− Mice
Histochemical analysis of Abcc6 −/− mice tissues has revealed positive von Kossa staining in the skin, the Bruch's membrane, and arteries. 13, 14 Our study provided additional information on the specific pattern of calcium deposition in the arterial tree. Indeed, we found that Abcc6 deficiency led to localize AC that could follow elastic fibers (wavy shape) or materialize as plaques or dot in more distal arteries. This observation may be in agreement with initiation of the mineralization on elastic fibers, 1 which extends with aging to form more substantial deposits. Furthermore, we found that tissue calcium content was 1.5 to 2× higher in the absence of Abcc6 (Figure 2 ). This phenotype is strikingly milder compared with other genetically modified mice invalidated for mineralization inhibitors such as Fetuin-A, Mgp, or osteopontin (Opn), where extensive calcification occurs throughout the vasculature. [17] [18] [19] In this respect, the primary role of Abcc6 as an inhibitor of calcification is still a matter of debate. 20
On the Nature of Vascular Cells Transdifferentiation Driven by Abcc6 Deficiency
Induction of chondro/osteogenic markers by vascular SMCs and loss of ECM mineralization inhibitors, such as Mgp or inorganic pyrophosphate (PPi), are commonly described as mechanisms underlying AC. 21 Using a quantitative PCR approach, we evidenced a transdifferentiation of vascular cells toward an osteochondrogenic phenotype in aged Abcc6 −/− . These changes were characterized by increased expression of (1) key transcription factors of osteogenesis (ie, Runx2), (2) the inducible inhibitor of calcification Opn, and (3) the cartilaginous type II collagen. The transcription factor Sox9 significantly decreased in WT but not in Abcc6 −/− arteries with aging, despite its expression according to genotype in aged animals did not reach significant difference. This observation together with accumulation of type II (cartilaginous) collagen suggests that an osteochondrogenic differentiation occurs in Abcc6 −/− mice arteries with aging. Recently, increased expression of Runx2, Sox9, Vdr, and Opn has been reported in dystrophic cardiac calcification-susceptible congenic mice, which also display a reduced Abcc6 expression, 22 after necrotic lesions. 23 High specific vitamin D responsive element is present in Opn promoter 24 and Runx2/Vdr was shown to cooperate in the transcriptional regulation of Opn. 25 This makes it likely that the increase in Opn transcription in Abcc6 −/− arteries depends on Vdr/Runx2 activity. Also, this suggests that Opn build-up is part of the PXE and not only a gene modifier of the pathology.
Sox9 tended to increase in arteries of old Abcc6 −/− mice. In accordance, the cartilaginous type II collagen gene, which depends on this transcription factor, increased. 26 In the context of Mgp deficiency, cellular differentiation is accompanied with decreased expression of SMC markers transgelin/ SM22, myocardine, and myosin. 27 Also, it was reported that Myocardin and Sox9 exert antagonistic effects during SMC chondrogenic transdifferentiation. 28 Such imbalance could not be observed in Abcc6 −/− arteries.
By contrast, we observed no difference in the expression level of Bmp largely documented to participate to AC associated with atherosclerotic lesions. Also, we found no significant change in Mgp expression level in Abcc6 −/− mice arteries. Mgp, as other Gla proteins, needs to undergo γ-carboxylation to become active. This process involves the γ-carboxylase GGCX and vitamin K as a cofactor and may represent determinant steps in the regulation of anticalcification in PXE. 29 Hence, Mgp γ-carboxylation status in arteries deserves special attention to evaluate potential deficiencies of this anticalcifying pathway in Abcc6 −/− arteries mineralization. Finally, we found no change in arterial expression level of the major physiological generator of PPi (Enpp1), the PPi transporters (Ank and Slc20a1), and the PPi-degrading alkaline phosphatase (Alpl). Unexpectedly, we found that Nt5e, encoding ecto-5' nucleotidase (CD73), which tended to increase with aging in WT, was reduced in Abcc6 −/− arteries.
This enzyme has been reported to mediate anticalcifying signaling 30 through the generation of adenosine from extracellular AMP hydrolysis. Although similarities were observed between PXE and ACDC (arterial calcification due to cd73 deficiency), the exploration of the possibility that the transported substance could be adenosine led to controversial reports 31, 32 so that the link between Abcc6 and CD73 remains to be established. These elements bring new pieces to the puzzle of PXE pathological mechanism where subpopulations of vascular cells may acquire phenotype and allow the local accumulation of cartilaginous (collagen IIA1) and bone (OPN) proteins and the nucleation hydroxyapatite crystals. 33 Although the induction of the above-mentioned genes was a factor 2 to 2.5, their level of expression remains low (cycle theshold ≥30 compared with house keeping genes cycle theshold ≈23-25). This is in accordance with the mild and focalized mineralization observed in Abcc6 −/− mice arterial tree. It is tempting to speculate that osteoblastic transdifferentiation in the context of Abcc6 deficiency is restrained to a subset of vascular cells proposed by others as mesenchymally derived subpopulation. 34 The question of how Abcc6 transporter exerts its remote effect on the vasculature remains unanswered. Both systemic (vitamin K, fetuin) and local (MGP) mechanisms of mineralization have been proposed in PXE, and it is assumed that ABCC6 transporter directly or indirectly releases a substance in the blood with anticalcifying properties. 2 This substrate remains elusive >14 years after the discovery that ABCC6 gene's mutations cause PXE. 35 Extensive work of many research teams was dedicated to the identification of this substrate, with no success. However, a recent publication showed that Abcc6 contributes indirectly to cytoplasmic adenylic nucleotides efflux. 36 For this reason, it was postulated that (liver) Abcc6 deficiency reduces circulating ATP and therefore its hydrolysis products first and foremost the anticalcifying PPi. This important discovery suggests that PPi is the principal anticalcifying molecule that lacks in Abcc6 −/− mice and possibly in patients with PXE. One may consider that reduced extracellular ATP in the context of Abcc6 deficiency may led not only to PPi but also to adenosine deficit, linking one more time PXE phenotype to the AC because of CD73 deficiency disease (adenosine-generating enzyme deficient).
Impact of Abcc6 Deficiency on Arterial Stiffness
Despite the lack of a significant change in the arterial structure (ie, IMT, diameter, and media cross-sectional area), Abcc6 −/− mice showed an increased carotid arterial stiffness with a lower distensibility and Einc/wall strain curve at younger age (9 months) than the WT mice. The impact of the Abcc6 deficiency on the arterial remodeling in PXE is controversial. In their study, Germain et al 7, 8 found a higher carotid IMT and WCSA, but unchanged distensibility and compliance with a lower wall strain in patients with PXE, when compared with age-and sex-matched controls. Similarly, IMT and distensibility were found higher in patients with PXE but with unchanged compliance. 9 The authors concluded that in PXE arteries, the effect of elastin fragmentation and proteoglycans replacement could obscure the effect of calcium accumulation on the arterial stiffness. It was proposed that the absence of arterial stiffening, despite reduced compliance with increasing age in patients with PXE, was because of increased amount of proteoglycans in the artery wall. Indeed, the fragmentation of the elastic fibers is usually associated with a reduced arterial stiffness. 37 Despite minimal calcifications, we did not observe fragmentation Contraction to PE and the thromboxane A2 analog (U46619) were obtained in mesenteric, tail, and carotid arteries isolated from male mice aged of 3, 12, and 24 mo. The sensitivity (pD2=−log efficient concentration 50%) and potency (Emax) are the mean±SEM of 3 to 10 independent experiments. PE indicates phenylephrine; and WT, wild type.
within elastic arterial fibers of Abcc6 −/− mice (not shown), which could explain the increased arterial stiffness observed only in the animal model as opposed to PXE patients. Altogether, these data suggest a complex rearrangement of the arterial wall structure in PXE leading to singular arterial biomechanics.
Impact of the Absence of Abcc6 on Arterial Reactivity
The absence of Abcc6 had a limited impact on receptor-dependent arterial contraction, despite a trend for a higher contractility. Similarly, no difference was found in endothelial-dependent and endothelial-independent relaxation. The absence of endothelial dysfunction in Abcc6 −/− clearly contrasts with calcifying metabolic diseases, such as diabetes mellitus, chronic renal insufficiency, or atherosclerosis, where early endothelial dysfunction occurs. 38 Interestingly, pressure-induced MT was increased in Abcc6 −/− resistance arteries in mice aged 12 and 24 months. In contrast with receptor-dependent contraction, MT relies primarily on a pressure-mediated mechanotransduction. 39 Similarly, MT is selectively modified, without changes in receptor-dependent tone, in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy characterized by gum accumulation in the extracellular matrix. 40 Thus, it is likely that AC in Abcc6 −/− animals does not interfere with arterial smooth muscle function and the ability of endothelial cells to release their relaxing factors. This observation is in agreement with the lack of clinical reports of vascular dysfunction in human PXE. However, MT unlike the adrenergic or renin-angiotensin system has no direct role on systemic pressure, but is involved in the control of local blood flow. A defect in MT causes improper perfusion pressure resulting in local tissue damages in the long term. For example, in type 2 diabetes mellitus, a reduced MT has been observed long before other organ damages are detected, and this is thought to contribute to the glomerular dysfunction occurring in this pathology. 41 Coronary artery spasm in response to dypiridamole infusion has been reported in 1 patient with PXE, 42 whereas another study has reported microangiopathic lesions in PXE, although unspecific. 12 However, beyond these studies, to our knowledge, few clinical observations suggest an exaggerated arterial tone in PXE. In animal models associated with a selective change in MT such as diabetic 4 or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy mice, 40 systolic blood pressure was found to be unchanged. Abnormal increased MT is also the hallmark of heart failure. 43 Indeed, as the increase in MT becomes obvious in older mice, we cannot exclude the occurrence of a slightly reduced heart function in association with changes in microvascular tone. Both are difficult to investigate in mice unless changes are largely a result of the animal's size. Although the limited calcification observed in Abcc6 −/− mice did not affect pharmacological vascular reactivity, in the long term, a reduced myogenic reactivity may Arterial dilatation in response to ACh and SNP were obtained in precontracted mesenteric, tail, and carotid arteries isolated from male mice aged of 3, 12, and 24 mo. The sensitivity (pD2=−log efficient concentration 50%) and potency (Emax) are the mean±SEM of 4 to 10 independent experiments. ACh indicates acetylcholine; SNP, sodium nitroprusside; WT, wild type. affect organs' integrity and act synergistically with other risk factors. Concerning the potential mechanisms involved in the gain of MT in Abcc6 −/− arteries, we excluded that a hypertrophic remodeling occurs (histomorphometry), which would have led most probably to increased pharmacological contractions. Then it is likely that specific signaling pathways involved in pressure sensing and MT are upregulated/facilitated in Abcc6 −/− arteries. Following the recent hypothesis that Abcc6 contributes to the transport of adenylic nucleotides in the blood stream, the increased myogenic response may result from reduced nucleotides or adenosine chronic exposure. Indeed, beside their vasoactive properties, vascular signaling by these molecules has been shown to initiate trophic effects, migration, and phenotypic changes of vascular cells. 44 
Blood Pressure Regulation and Abcc6
Finally, despite a slight increase in arterial stiffness and a gain of vasoconstrictor sensitivity, Abcc6 −/− animals did not show increased arterial blood pressure. This observation is even more striking, taking into consideration the fact that heart rate was increased in aged animals ( Table 2 ). Together with the absence of a high blood pressure, increased heart rate and cardiac hypertrophy recently described in Abcc6 −/− mice 45 may be linked to the increased myogenic reactivity, a hallmark of chronic heart failure, 43 although the causal link remains to be established.
It is noteworthy that many genetically modified mouse strains display mild spontaneous phenotype probably because of functional compensations, and some manifestations may be unmasked by physiological challenge. Notably and in contrary to humans, mice are not prone to atherosclerosis unless the Ldlr or ApoE genes are knocked out. Such confounding factors could probably modulate the phenotypic arterial expression in the human disease. 9 Nitschke et al 46 showed that ENPP1 (ectonucleotide pyrophophatase/phosphodiesterase), another player of ectopic vascular calcification, is an active contributor to the development of atherosclerosis in ApoEdeficient mice. Thus, if Abcc6 function is part of a complex regulator pathway and works in synergy with other modulators of ectopic calcification, its actual physiological role could be revealed in other pathophysiological contexts. Myogenic tone, measured as the difference between active (in PSS) and passive diameters, was not affected by the absence of Abcc6 in 3-month-old mice (C and D). However, it was significantly increased in 12-month-old Abcc6 −/− , when compared with that in WT mice in the tail artery, whereas the difference was not significant in the mesenteric artery (E and F). Furthermore, myogenic tone was significantly higher in 24-month-old Abcc6 −/− than in WT mice in both tail and mesenteric arteries (G and H).
Conclusions
In the present study, we showed that Abcc6 deficiency in mice reproduced the arterial calcified phenotype of human PXE. Furthermore, our study highlighted an unexpected increased MT and a mild increase in arterial stiffness and mostly in the aged animals. This phenotype is in favor of a higher susceptibility to cardiovascular risk factors and makes Abcc6 −/− another key player for the development of arteriosclerosis, which underlying mechanism remains to be determined.
